Hyperactive children and the efficacy of psychoactive drugs as a treatment intervention.
Characteristics of hyperactive children, including speculation in regard to etiology, are reviewed. Drug effects studies and drug treatment of hyperactive behavior are examined, and unresolved issues are discussed. Conclusions indicate that individual differences in hyperative children should form the basis for treatment planning, rather than simply treating groups of children under the rubric "hyperactivity."
D000662:Amphetamines / Q000627:therapeutic use; D000697:Central Nervous System Stimulants / Q000627:therapeutic use*; D002652:Child Behavior / Q000187:drug effects; D002707:Chlordiazepoxide / Q000627:therapeutic use; D002746:Chlorpromazine / Q000627:therapeutic use; D003376:Counseling; D003642:Deanol / Q000627:therapeutic use; D003913:Dextroamphetamine / Q000627:therapeutic use; D004519:Education, Special; D006801:Humans; D006948:Hyperkinesis / Q000188:drug therapy* / Q000209:etiology; D007099:Imipramine / Q000627:therapeutic use; D007858:Learning / Q000187:drug effects; D007859:Learning Disabilities / Q000209:etiology; D008774:Methylphenidate / Q000627:therapeutic use; D011613:Psychotherapy; D011619:Psychotropic Drugs / Q000627:therapeutic use*; D014888:Wechsler Scales
D000662:Amphetamines; D000697:Central Nervous System Stimulants; D011619:Psychotropic Drugs; D008774:Methylphenidate; D003642:Deanol; D002707:Chlordiazepoxide; D007099:Imipramine; D003913:Dextroamphetamine; D002746:Chlorpromazine